1. Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression
- Author
-
Xinghui Pan, Kaibao Ji, Xu Zhang, Ruihan Xiao, Yulian Pang, Mengqi Qin, Piaopiao Hu, and Nan Sun
- Subjects
0301 basic medicine ,Male ,Retinal Ganglion Cells ,endocrine system ,genetic structures ,Cell Survival ,Ischemia ,Down-Regulation ,Apoptosis ,Resveratrol ,Pharmacology ,resveratrol ,Protective Agents ,Neuroprotection ,Retinal ganglion ,Retina ,GTP Phosphohydrolases ,Superoxide dismutase ,sirtuin1 ,Rats, Sprague-Dawley ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Genetics ,medicine ,Animals ,Viability assay ,optic atrophy 1 ,Cells, Cultured ,biology ,Superoxide Dismutase ,Glaucoma ,General Medicine ,Articles ,medicine.disease ,eye diseases ,Mitochondria ,Rats ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Reperfusion Injury ,biology.protein ,neuroprotection ,sense organs - Abstract
Loss of idiopathic retinal ganglion cells (RGCs) leads to irreversible vision defects and is considered the primary characteristic of glaucoma. However, effective treatment strategies in terms of RGC neuroprotection remain elusive. In the present study, the protective effects of resveratrol on RGC apoptosis, and the mechanisms underlying its effects were investigated, with a particular emphasis on the function of optic atrophy 1 (Opa1). In an ischemia/reperfusion (I/R) injury model, the notable thinning of the retina, significant apoptosis of RGCs, reduction in Opa1 expression and long Opa1 isoform to short Opa1 isoform ratios (L‑Opa1/S‑Opa1 ratio) were observed, all of which were reversed by resveratrol administration. Serum deprivation resulted in reductions in R28 cell viability, superoxide dismutase (SOD) activity, Opa1 expression and induced apoptosis, which were also partially reversed by resveratrol treatment. To conclude, results from the present study suggest that resveratrol treatment significantly reduced retinal damage and RGC apoptosis in I/R injury and serum deprivation models. In addition, resveratrol reversed the downregulated expression of Opa1 and reduced SOD activity. Mechanistically, resveratrol influenced mitochondrial dynamics by regulating the L‑Opa1/S‑Opa1 ratio. Therefore, these observations suggest that resveratrol may exhibit potential as a therapeutic agent for RGC damage in the future.
- Published
- 2020